Publications
Text queries can be conducted by Author, Title, or Keyword.
Functional connectivity among brain regions affected in Alzheimer's disease is associated with CSF TNF-? in APOE4 carriers
Source: NeuroImage 2020 Feb;86:112-122.
Author: Joey Annette Contreras , Vahan Aslanyan , Melanie D , Sweeney , Lianne M , Abhay P , Berislav V. Zlokovic
PubMed ID: 31870643
Abstract:
It is now recognized that understanding how neuroinflammation affects brain function may provide new insights into Alzheimer's pathophysiology. Tumor necrosis factor (TNF)-?, an inflammatory cytokine marker, has been implicated in Alzheimer's disease (AD), as it can impair neuronal function through suppression of long-term potentiation. Our study investigated the relationship between cerebrospinal fluid TNF-? and functional connectivity (FC) in a cohort of 64 older adults (? age = 69.76 years; 30 cognitively normal, 34 mild AD). Higher cerebrospinal fluid TNF-? levels were associated with lower FC among brain regions important for high-level decision-making, inhibitory control, and memory. This effect was moderated by apolipoprotein E-?4 (APOE4) status. Graph theory metrics revealed there were significant differences between APOE4 carriers at the node level, and by diagnosis at the network level suggesting global brain network dysfunction in participants with AD. These findings suggest proinflammatory mechanisms may contribute to reduced FC in regions important for high-level cognition. Future studies are needed to understand the role of inflammation on brain function and clinical progression, especially in APOE4 carriers.
Source: NeuroImage 2020 Feb;86:112-122.
Author: Joey Annette Contreras , Vahan Aslanyan , Melanie D , Sweeney , Lianne M , Abhay P , Berislav V. Zlokovic
PubMed ID: 31870643
Abstract:
It is now recognized that understanding how neuroinflammation affects brain function may provide new insights into Alzheimer's pathophysiology. Tumor necrosis factor (TNF)-?, an inflammatory cytokine marker, has been implicated in Alzheimer's disease (AD), as it can impair neuronal function through suppression of long-term potentiation. Our study investigated the relationship between cerebrospinal fluid TNF-? and functional connectivity (FC) in a cohort of 64 older adults (? age = 69.76 years; 30 cognitively normal, 34 mild AD). Higher cerebrospinal fluid TNF-? levels were associated with lower FC among brain regions important for high-level decision-making, inhibitory control, and memory. This effect was moderated by apolipoprotein E-?4 (APOE4) status. Graph theory metrics revealed there were significant differences between APOE4 carriers at the node level, and by diagnosis at the network level suggesting global brain network dysfunction in participants with AD. These findings suggest proinflammatory mechanisms may contribute to reduced FC in regions important for high-level cognition. Future studies are needed to understand the role of inflammation on brain function and clinical progression, especially in APOE4 carriers.